Daxor Net Income 2012-2011 | DXR

Daxor net income from 2012 to 2011. Net income can be defined as company's net profit or loss after all revenues, income items, and expenses have been accounted for.
Unlock Macrotrends Premium
40 years of data
Faster, ad-free pages
Unlimited data exports
Full-width charts
Daxor Annual Net Income
(Millions of US $)
2011 $-7
Daxor Quarterly Net Income
(Millions of US $)
2011-12-31 $-1
2011-09-30 $-4
Sector Industry Market Cap Revenue
Medical Medical - Outpatient & Home Care $0.068B $0.000B
Daxor Corporation is a medical device manufacturing corporation with additional biotech services.
Stock Name Country Market Cap PE Ratio
Fresenius SE (FSNUY) Germany $29.874B 13.39
Quest Diagnostics (DGX) United States $27.271B 23.22
DaVita (DVA) United States $12.368B 15.15
Encompass Health (EHC) United States $12.224B 21.22
Elanco Animal Health (ELAN) United States $11.421B 21.57
Chemed (CHE) United States $6.665B 23.76
RadNet (RDNT) United States $5.964B 172.23
LifeStance Health (LFST) United States $4.888B 98.39
Option Care Health (OPCH) United States $3.665B 15.49
Aveanna Healthcare Holdings (AVAH) United States $3.112B 21.61
Addus HomeCare (ADUS) United States $2.213B 20.02
Astrana Health (ASTH) United States $2.101B 22.31
Pennant (PNTG) United States $1.484B 38.62
U.S Physical Therapy (USPH) United States $1.244B 32.83
MEDIROM Healthcare Technologies (MRM) Japan $0.022B 0.00
Psychemedics (PMD) United States $0.000B 0.00